Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-08-010106
Filing Date
2008-11-25
Accepted
2008-11-25 15:56:15
Documents
1
Period of Report
2008-11-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 3844
  Complete submission text file 0001127602-08-010106.txt   5756
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address MERCK MEDCO MANAGED CARE INC 100 SUMMIT AVE MONTVALE NJ 07645
Business Address 2107823850
ATIEH MICHAEL G (Reporting) CIK: 0001072501 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-15190 | Film No.: 081213845